These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22999267)

  • 21. Guidelines for radiation injury to bowel and bladder from external irradiation alone.
    Nussbaum H; Kagan AR; Wollin M; Rao A; Hintz B; Gilbert H; Chan P; Winkley J; Kwan D
    Cancer Clin Trials; 1981; 4(3):295-9. PubMed ID: 7285276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quality of life after radiotherapy for prostate cancer].
    Joly F; Degrendel AC; Guizard AV
    Cancer Radiother; 2010 Oct; 14(6-7):519-25. PubMed ID: 20728393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Benefit of intensity modulated and image-guided radiotherapy in prostate cancer].
    Latorzeff I; Mazurier J; Boutry C; Dudouet P; Richaud P; de Crevoisier R
    Cancer Radiother; 2010 Oct; 14(6-7):479-87. PubMed ID: 20797889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reconstruction of radiation-induced injuries of the lower urinary tract.
    Ballek NK; Gonzalez CM
    Urol Clin North Am; 2013 Aug; 40(3):407-19. PubMed ID: 23905939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer.
    Nuyttens JJ; Robertson JM; Yan D; Martinez A
    Cancer Radiother; 2004 Oct; 8(5):297-304. PubMed ID: 15561595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy.
    Perna L; Alongi F; Fiorino C; Broggi S; Cattaneo Giovanni M; Cozzarini C; Di Muzio N; Calandrino R
    Radiother Oncol; 2010 Oct; 97(1):71-5. PubMed ID: 20307910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Phase II trial of arc-based hypofractionated intensity-modulated radiotherapy in localized prostate cancer.
    Lock M; Best L; Wong E; Bauman G; D'Souza D; Venkatesan V; Sexton T; Ahmad B; Izawa J; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1306-15. PubMed ID: 20708855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients.
    Cozzarini C; Fiorino C; Da Pozzo LF; Alongi F; Berardi G; Bolognesi A; Briganti A; Broggi S; Deli A; Guazzoni G; Perna L; Pasetti M; Salvadori G; Montorsi F; Rigatti P; Di Muzio N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):191-9. PubMed ID: 21109361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapy.
    Pervez N; Small C; MacKenzie M; Yee D; Parliament M; Ghosh S; Mihai A; Amanie J; Murtha A; Field C; Murray D; Fallone G; Pearcey R
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):57-64. PubMed ID: 19395192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies.
    Georg P; Georg D; Hillbrand M; Kirisits C; Pötter R
    Radiother Oncol; 2006 Jul; 80(1):19-26. PubMed ID: 16766068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Late injury of the gastrointestinal tract following radiotherapy].
    Mateev V; Nachev E; Kamenov G; Todorov D
    Khirurgiia (Sofiia); 1973; 26(6):485-9. PubMed ID: 4798847
    [No Abstract]   [Full Text] [Related]  

  • 32. Radiation as primary therapy for rectal carcinoma.
    Sklaroff DM
    Am Fam Physician; 1973 Jul; 8(1):81-5. PubMed ID: 4124834
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hazards of pelvic radiotherapy].
    Chassagne D; Eschwege F
    Rev Prat; 1972 Nov; 22(28):3829-37. PubMed ID: 4649017
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer.
    Zapatero A; Roch M; Büchser D; Castro P; Fernández-Banda L; Pozo G; Liñán O; Martin de Vidales C; Cruz-Conde A; García-Vicente F
    Clin Transl Oncol; 2017 Sep; 19(9):1161-1167. PubMed ID: 28374321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients?
    Vistad I; Cvancarova M; Fosså SD; Kristensen GB
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1335-42. PubMed ID: 18355976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.
    Vesprini D; Sia M; Lockwood G; Moseley D; Rosewall T; Bayley A; Bristow R; Chung P; Ménard C; Milosevic M; Warde P; Catton C
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e415-21. PubMed ID: 21477939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensity modulated neutron radiotherapy for the treatment of adenocarcinoma of the prostate.
    Santanam L; He T; Yudelev M; Forman JD; Orton CG; Heuvel FV; Maughan RL; Burmeister J
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1546-56. PubMed ID: 17674984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does sucralfate reduce radiation-induced diarrhea?
    Henriksson R; Franzén L; Littbrand B
    Acta Oncol; 1987; 26(1):76-7. PubMed ID: 3593576
    [No Abstract]   [Full Text] [Related]  

  • 39. A prospective pilot study of target-guided personalized chemotherapy with intensity-modulated radiotherapy in patients with early rectal cancer.
    Cubillo A; Hernando-Requejo O; García-García E; Rodriguez-Pascual J; De Vicente E; Morelli P; Rubio C; López-Ríos F; Muro A; López U; Prados S; Quijano Y; Hidalgo M
    Am J Clin Oncol; 2014 Apr; 37(2):117-21. PubMed ID: 23211222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Causes and therapy of early reactions of bladder and intestines to radiations].
    BUTTENBERG D
    Strahlentherapie; 1958 Feb; 105(2):218-23. PubMed ID: 13543538
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.